Skip to main content
PLOS One logoLink to PLOS One
. 2023 Jan 12;18(1):e0280264. doi: 10.1371/journal.pone.0280264

Factors influencing the use of therapeutic footwear in persons with diabetes mellitus and loss of protective sensation: A focus group study

Athra Malki 1,*, Gijsbertus J Verkerke 1,2, Rienk Dekker 1, Juha M Hijmans 1
Editor: Dimitrios Sokratis Komaris3
PMCID: PMC9836263  PMID: 36634096

Abstract

Background

Persons with diabetes mellitus (DM) and loss of protective sensation (LOPS) due to peripheral neuropathy do not use their therapeutic footwear (TF) consistently. TF is essential to prevent foot ulceration. In order to improve compliance in using TF, influencing factors need to be identified and analyzed. Persons with a history of foot ulceration may find different factors important compared with persons without ulceration or persons who have never used TF. Therefore, the objective of this study was to determine factors perceived as important for the use of TF by different groups of persons with DM and LOPS.

Method

A qualitative study was performed using focus group discussions. Subjects (n = 24) were divided into 3 focus groups based on disease severity: ulcer history (HoU) versus no ulcer history (no-HoU) and experience with TF (TF) versus no experience (no-TF). For each group of 8 subjects (TF&HoU; TF&no-HoU; no-TF&no-HoU), an online focus group discussion was organized to identify the most important influencing factors. Transcribed data were coded with Atlas.ti. The analysis was performed following the framework approach.

Results

The factors comfort and fit and stability/balance were ranked in the top 3 of all groups. Usability was ranked in the top 3 of group-TF&noHoU and group-noTF&noHoU. Two other factors, reducing pain and preventing ulceration were ranked in the top 3 of group-TF&noHoU and group-TF&HoU, respectively.

Conclusion

Experience with TF and a HoU influence which factors are perceived as important for TF use. Knowledge of these factors during the development and prescription process of TF may lead to increased compliance. Although the main medical reason for TF prescription is ulcer prevention, only 1 group gave this factor a high ranking. Therefore, next to focusing on influencing factors, person-centered education on the importance of using TF to prevent ulcers is also required.

Introduction

Diabetes Mellitus (DM) is one of the most common chronic conditions worldwide, affecting 422 million people [1]. The lifetime risk of developing a diabetic foot ulcer (DFU) in this population can be as high as 25%. Approximately 85% of diabetes-related lower extremity amputations are preceded by a DFU [2]. Therefore, DFUs are considered a major concern in healthcare, both from a quality of life and an economic perspective [3]. The largest risk factor for developing DFU is peripheral neuropathy [4, 5]. Sensory neuropathy causes insensitivity, leading to loss of protective sensation (LOPS). Additionally, a limited range of motion, atrophy of the small muscles in the foot, and changes in foot structure due to DM cause elevated plantar pressure. Repetitive stress on the areas with high plantar pressure leads to small wounds that may remain unnoticed due to the neuropathy, resulting in DFUs [6].

According to the International Working Group on the Diabetic Foot (IWGDF) guidelines on the prevention and management of the diabetic foot, persons with DM with a high risk of developing ulcers need to use therapeutic footwear (TF) in order to offload high plantar pressure [7]. The risk of developing DFUs can be reduced significantly by using offloading footwear for most of the day [8, 9]. However, several studies have shown low adherence to use of TF in persons with DM [1012]. In order to improve adherence and prevent further deterioration of the condition of the foot, it is important to increase knowledge and awareness among persons with DM as well as to identify factors that are perceived as important for the use of TF [11]. This information can be used for the (future) development of TF and further improvement of the prescription process.

In a review published in 2016, only 6 quantitative observational studies were found to investigate adherence to use of TF in persons with DM [13]. Most studies in the review reported associations of different factors with adherence: foot deformity and minor amputation, perceived severity of the foot condition, TF appearance, body mass index, diabetes type, and age [13]. Due to the limited number of studies and inconsistent outcomes, it remains uncertain which factors influence adherence to use of TF. The inconsistent outcomes might be explained by the limited attention paid by researchers to the distinction between group and individual-level predictors of adherence. The heterogeneity of the group of persons with DM and foot complications likely explains the strong variation between individuals in TF use, thereby leading to predictors of adherence to only exist on individual or subgroup level [13].

A qualitative study is a suitable means to generate new knowledge on factors that are perceived as important for the use of TF (in different groups of persons with DM and LOPS). This type of methodology is not limited by pre-specified questions and can therefore identify the most important factors as well as the underlying perceptions, experiences, and wishes of participants regarding use of TF [14]. Focus group discussions with room for interaction will likely result in a fruitful discussion where ideas emerge that provide in-depth insight into the topic [15].

Since the population with DM is heterogeneous, in this study different groups of persons with DM and LOPS are distinguished, based on severity of the disease (HoU versus no-HoU) and experience with TF. It is expected that persons who have experienced the impact of an ulcer (long healing time and necessity of good wound care) [16, 17]) will have different motivations for using TF compared with persons without ulcers. Other influencing factors are duration of TF use, positive or negative experiences with TF use, and type of footwear used. The aim of this study is to provide insight into the factors perceived as important (weight) by different groups of persons with DM and LOPS when using TF (based on severity of the disease and experience in using TF).

Method

The Medical Ethics Committee of the University Medical Center Groningen (UMCG) declared that the study falls outside the scope of the Dutch law on Medical Research involving Human Subjects (WMO). Therefore, no formal approval was required from the committee (METc 2020/524). The required legal acts and/or guidelines, the Medical Treatment Agreement (WGBO), General Data Protection Regulation (GDPR) and, codes of conduct of the FEDERA (Federation of Medical Scientific Institutions) were followed.

Subjects

Persons who visited physicians working at the Department of Rehabilitation Medicine of the UMCG or outside the UMCG, such as general practitioners or pedorthists (e.g., OIM Haren, the Netherlands) were recruited for this study. Subjects were also recruited from previous research (METc 2018/240), social media (e.g., Facebook and LinkedIn) and digital platforms (e.g., Diabetes Vereniging Nederland, Diabetesfonds, and Diabetes Trefpunt Nederland). Subjects were included in this study if they were diagnosed with DM, diagnosed with LOPS (self-reported), aged 18 years or older, able to speak Dutch, able to answer general questions, and able to attend the digital focus group discussion. The exclusion criteria were: having pain as the main complaint or not being able to walk independently. A purposive sample of eligible subjects who met the criteria were either contacted by phone, email or both and received an information letter with a written informed consent form. Eligible subjects were divided into 3 groups (8 subjects per group) based on disease severity (HoU versus no-HoU) and experience in using TF (experience versus no experience). For each group, additional group-level-related selection criteria were added. These criteria are shown in Fig 1.

Fig 1. Inclusion and exclusion criteria for the 3 focus groups.

Fig 1

*TF = (orthopedic shoes (OS), semi-orthopedic shoes (semi-OS), or adaptation to ready-made shoes).

Study design and data collection

A qualitative study was performed consisting of 3 focus group discussions. The Consolidated Criteria for reporting Qualitative Studies Checklist (COREQ) was used for reporting the outcomes (see S1 File for COREQ Checklist) [18].

Prior to the focus group discussions, a self-reporting questionnaire was sent to all (24) subjects to gain knowledge about their disease and TF use (number of days per week and hours per day). Information on LOPS, foot deformities, HoU, prescribed devices, and months of TF use was retrieved. Additionally, the questionnaire was used to determine characteristics such as gender, age, body weight, and height. Due to the COVID-19 pandemic, physical measurements were not possible, which is why the information on the LOPS (diagnosed by a physician in a neurological assessment prior to this study), foot deformities (diagnosed by a physician prior to this study), body weight, and height was self-reported. In addition, the focus group discussions could not be held in person due to the COVID-19 pandemic. Therefore, the group discussions were held online using Microsoft Teams©.

Prior to the online meetings, all subjects received a letter with instructions on how the discussion was to be organized. If they had questions or needed more guidance, the first author of this study (AM) could be contacted prior to the focus group discussion. When joining the online meeting, subjects were informed (again) that the discussions were audio and video recorded and that they had to reaffirm consent. Thereafter, the moderator explained the purpose of the study, followed by a brief introduction of the subjects and the discussion round.

An interview guide (see S2 & S3 Files) with open-ended questions was developed. The questions were related to factors/subthemes that have been reported to (likely) influence a person’s decision to use TF [11, 1921]. Also, some general questions based on experience with TF and other topics (see S2 & S3 Files) were discussed during the focus group discussions [22]. The questions (order and formulation) were analyzed and discussed several times by the researchers and moderator(s) of this study in online meetings.

The total duration of each focus group discussion was 2 hours (including a 10-minute break). After the final focus group discussion, all recordings were analyzed.

Moderator(s) and data coders

The moderator was an independent researcher (LK, PhD) experienced in conducting qualitative research. The assistant moderator, a PhD student (first author, AM) at the Department of Rehabilitation Medicine, UMCG supported the main moderator together with another researcher (RG, Human Movement Sciences Master student, University of Groningen) in logistical matters. An experienced qualitative researcher (last author, JMH) was also present at the focus group discussions. His role during the discussions was to ensure the focus group discussions proceeded according to plan and to answer questions from subjects. All of the researchers present during the focus group discussion were not acquainted with the subjects in advance.

Data analysis

The recordings of all 3 discussions were transcribed verbatim by the first author. All subjects were given a coding number to preserve anonymity. Analysis of the transcriptions was performed with the Atlas.ti software package (Scientific Software Development GmbH, version 8.4.5 for Windows or Mac). The analysis process described below consists of different phases following the framework approach [23].

  1. Read and re-read 3 transcriptions of the 3 focus group discussions.

  2. Code 10% of 1 transcription (AM) and evaluate the initial codes (JMH).

  3. Consensus meeting between (AM) and (JMH) to discuss initial codes and identify themes, subthemes, and factors (= code belonging to a certain subtheme).

  4. Revision of the initial codes of 1 transcription and form a preliminary version of the thematic framework (AM).

  5. Consensus meeting between (AM) and (JMH) to discuss the revised codes and the thematic framework.

  6. Open coding first 10% of the 2 other transcriptions (AM) and evaluate the codes (JMH) and the thematic framework.

  7. Consensus meeting between (AM) and (JMH) to discuss the new and revised codes and the thematic framework.

  8. Code remaining 90% of 1 transcription (AM).

  9. Consensus meeting between (AM) and (JMH) to discuss new and revised codes and the thematic framework.

  10. Code remaining 90% of the 2 other transcriptions (AM). During this phase, data saturation was confirmed since no new themes, subthemes, and/or factors had to be added.

  11. Consensus meeting between (AM) and (JMH) to discuss the final thematic framework.

  12. Summarize quotes on the subthemes/ and or factors that were extensively discussed (AM) (Atlas.ti showed the frequency of the mentioned subthemes and factors) during the focus group discussions.

  13. Consensus meeting between (AM) and (JMH) to discuss summaries on subthemes and/or factors.

The focus group discussions were held in Dutch. The data analysis (transcription and coding) was also performed in Dutch. All quotes presented in the result section were translated from Dutch to English (by a Dutch-speaking person).

Results

A total of 24 subjects with DM and LOPS participated in 3 focus group discussions, with each group consisting of 8 subjects. The mean ages were 64, 63.9, and 63 years in group-noTF&noHoU, group-TF&noHoU, and group-TF&HoU, respectively. The male-to-female ratio differed for each focus group. Characteristics of the subjects are shown in Table 1 (see S1 Table for the extended non-diabetes related comorbidities per focus group). This information was gathered from the questionnaire sent out to the (24) subjects. Other information gathered from the questionnaire was related to subjects’ knowledge of their condition (cause of DFU) and whether they perceive TF as a solution for their complaints. Additional information on knowledge about reasons for TF prescription and types of footwear that exist became apparent during the start of the focus group discussion. This information can be found in Table 2.

Table 1. Characteristics of the subjects of the focus group discussions.

Characteristics Group-noTF&noHoU
n = 8
Group-TF&noHoU
n = 8
Group-TF&HoU
n = 8
Age (years ± range) 64 ± 25 63.9 ± 26 63 ± 17
Sex (male/female) 5/3 3/5 6/2
Comorbidities (non-diabetes related)
    Hypertension 4 4 4
    Arthrosis (back/hip/knee/wrists) 2 5 1
    Heart failure/arrhythmia 0 3 3
    Sleep apnea 1 2 1
    Other 3 6 3
Type of current TF (number of pairs of TF)
    No TF 3 0 0
    Inlays 5 1* 0
    Adaptation to ready-made shoes 0 1 0
    Semi-OS 0 2 2
    OS 0 4 6
Time since prescription of current TF (years ± SD) 15.0 ± 9.5 3.3 ± 1.7 3.9 ± 3.7
Use of current TF
    Days per week (number of days ± SD) 5.8 ± 2.5 6.0 ± 2.6 7.0 ± 0.0
    Hours per day (number of hours ± SD) 1.7 ± 1.2 7.1 ± 4.4 9.4 ± 3.3
Walking ability (distance)
    0 m 0 0 0
    0–10 m 0 0 0
    10–50 m 1 0 0
    50–200 m 0 1 1
    200 m– 1 km 0 4 4
    More than 1 km 7 3 3

Group-noTF&noHoU: group with no therapeutic footwear and no history of ulceration.

Group-TF&noHoU: group with therapeutic footwear and no history of ulceration.

Group-TF&HoU: group with therapeutic footwear and history of ulceration.

TF: therapeutic footwear, HoU: history of ulceration, semi-OS: semi-orthopedic shoes

OS: orthopedic shoes.

*Used semi-OS and OS in the past; however, they felt too heavy, which is why the subject returned to using inlays (this was also the case when the focus group discussion took place).

Table 2. Knowledge on the reasoning behind and function of TF and the list of factors that are perceived as important by the different groups of subjects with DM.

Knowledge on the reasoning behind and function of TF
Subjects in all groups seemed to have sufficient knowledge about the complications of having diabetes. Group-noTF&noHoU and Group-TF&HoU mentioned neuropathy and pressure spots as complications. Callus formation, pain (Group-noTF&noHoU), foot deformities (Group-TF&HoU), and ulcers (all groups) were also mentioned as diabetes-related complications. All groups seemed to know TF is prescribed to prevent DFUs. Other benefits of using TF were also mentioned, such as walking with less effort and pain, better stability, maintaining foot health (Group-noTF&noHoU), reducing pain, and improving balance (Group-TF&noHoU).
Factors perceived as important
Ranka Group-noTF&noHoU Group-TF&noHoU Group-TF&HoU
1 Comfort and fit Comfort and fit Comfort and fit
2 Stability/balance Reducing pain Stability/balance
3 Usability (weather/material/activity) Stability/balance * Preventing ulceration(reducing pressure)
4 Appearance Usability(weather/material/activity) * Reducing pain
5 Donning and doffing Weight Walking quality (improving walking distance)
6 Weight Walking quality (improving walking distance) Usability (weather/material/activity)
7 Preventing ulceration Appearance Donning and doffing
8 Reducing pain* Donning and doffing* Prescription process by physician/pedorthist
9 Walking quality* (improving walking distance) Prescription process by* physician/pedorthist Appearance
10 Prescription process by* physician/pedorthist Preventing ulceration* Weight
Additional factors coded during data analysis (random order, not ranked)
Durability
Location (indoors/outdoors, special occasion, work etc.)
Type/number of pairs
Sole thickness

Group-noTF&noHoU: group with no therapeutic footwear and no history of ulceration.

Group-TF&noHoU: group with therapeutic footwear and no history of ulceration.

Group-TF&HoU: group with therapeutic footwear and history of ulceration.

TF: therapeutic footwear, HoU: history of ulceration.

aThe factors set in bold are the factors the subjects in the 3 different groups ranked in the top 3. Ranks 4 to 10 are based on the number of times the factors were mentioned as important during the focus group sessions.

*Same ranking of different factors per group.

Results of the ranking process and most frequently coded factors/subthemes

During the focus group discussions, subjects were asked to rank the influencing factors from most (= highest rank) to least (= lowest rank) important. Data analysis followed after the focus group discussions. During the data analysis, additional factors (and subthemes and themes) were coded (see S4 File for the final framework). These codes do not have a ranking because they were coded after the focus group discussions took place. The input of subjects on factors that were coded often and/or ranked during the focus group discussion was summarized per group. In Table 2, results of the data analysis are shown. It is important to note that certain definitions (i.e., usability) were further divided into different factors during the data analysis process. For example, the factors appearance and prescription process are also ranked in Table 2. Both are subthemes, but in order to make the discussion easy to follow, these subthemes are referred to as factors as well. All other factors shown in Table 2 can be grouped under the subthemes use, effectiveness, and usability of TF. The input given by each group is shown in Table 2 and further outlined in the section below. It is important to note that input of group-noTF&noHoU was based on future use of TF and that this group had no prior experience with TF (except for inlays).

Main findings

Group-noTF&noHoU factors belonging to the subthemes use, effectiveness, usability, appearance, and prescription process of (non-) TF

Comfort and fit. During the discussion, subjects mentioned the importance of having comfortable and well-fitting footwear, not only for walking long distances but also for indoor use. Subjects in this group ranked comfort and fit of TF as the most important factor influencing their (future) use of TF. According to this group, comfortable footwear should meet the following criteria: soft and cushioned, light, and seamless.

D1.6: …but what is important, uh that is uh that it has decent shock absorption, that it is a bit soft, uh so that it has enough cushioning. I think that is very important.

Stability. Stability when using TF was not discussed extensively; however, it was ranked as the second most important factor. According to one subject (D1.7), it is not possible to make a move without using sturdy footwear because this provides the required support and stability during walking. The same subject used shoes the whole day for fear of falling.

D1.7: …. If I take them off, then I cannot take a single step forward. Even even with with the balance and so on, eh then it is done. I already fell a couple of times. Because I just, well, maybe not necessarily have stability issues, but I am not able to stand up straight.

Weather and material. The weather and material of TF were the third most important factors. Again, these factors were not discussed extensively. Only one subject (D1.2) mentioned that TF needs to have cushioning and has to be made of breathable and waterproof material. Another subject (D1.5) mentioned the added value of having TF in the form of sandals for the summer.

D1.5: But what I am also very curious about is when you have closed-toe shoes for the winter, what about summer shoes. Are there sandals that can be adapted to uh to an OS. I am actually very curious about that. For example, with an open uh toe or uh, well that seems dangerous for a diabetic by the way. And I was not allowed to wear sandals for a long time, by the way, but secretly I do wear sandals in the summer when it is very hot, as it can get really hot nowadays in the Netherlands. I put my inlays, my my orthotics in them.

Appearance and sole thickness. Appearance was ranked just outside the top 3 of most important factors. However, in contrast to some of the aforementioned and higher ranked factors, this particular factor was discussed extensively during the focus group discussion. The factor sole thickness was not ranked during the focus group discussion; however, it was coded during the data analysis and was linked to appearance. Most subjects mentioned that although appearance of TF is important for their future decision to use TF, it is less important than using comfortable footwear. However, when the researchers’ prototype shoes (sporty look with thick midsoles, see S1 Fig for prototype shoes) were shown, most subjects did not like the shoes and mentioned they would not use them unless they had to. They felt the shoes were not appropriate for more formal occasions (e.g., visits, weddings). According to some subjects, the prototype shoes only met the standards for outdoor use, such as walking. Only one subject (D1.7) was willing to use the prototype shoes; however, even this subject preferred to change the colors of the shoes.

D1.8: Uh so as to the appearance of the shoes. I think uh that with outdoor shoes, they should look a bit decent. Because you have to go to occasions where you have to look a little bit more decent sometimes, so to speak. But uh with shoes that I only use indoors, then it does not really matter to me, as long as they are comfortable. It does not matter what they look like.

Donning and doffing and weight. The factors donning and doffing and weight of the shoes were not rated highly. Both factors were also not discussed extensively within this group. Only 2 subjects (D1.2 & D1.5) mentioned that the donning and doffing process should be easy to perform. Three subjects (D1.2, D1.5 & D1.8) mentioned the importance of lightweight footwear, especially for indoor use (D1.5).

D1.5: And uh when you are indoors and yes I am also at an age where I do not have a very busy life anymore. So I go outside for an hour or so every day, but other than that, I am busy indoors. And if you always have to wear those heavy, somewhat stiff shoes, well, I would not like that.

Preventing ulceration. Preventing ulceration was not ranked highly. Nevertheless, it was discussed extensively during the focus group discussion. Subjects were aware of the important role of TF in preventing ulceration. They also mentioned that feet stay healthy longer when using TF, wide feet in particular (D1.7). One subject (D1.5) also mentioned that TF should be seamless in order to prevent shear stress, which may result in wounds.

D1.7: The width of the foot, yes I always have uh well problems with that. It it pinches too much. And then those pressure points emerge uh uh emerge on my foot.

Reducing pain, walking quality, and prescription process. The factors reducing pain, walking quality, and prescription process were considered the least important factors. The factors pain reduction and walking quality were also not discussed extensively. In general, subjects mentioned that using TF could lead to walking with less effort and pain. Contrary to the 2 other factors, the factor prescription process was discussed extensively. Subjects mentioned they want to be involved during the prescription process and that physicians and/or pedorthists should listen to their wishes and give them feedback on the existing possibilities. They wanted to be able to express their opinion on the appearance of TF and discuss the level of comfort and stability of the footwear. Finally, subjects also found it important for their prescribing professional to be knowledgeable and experienced.

D1.4: Well I uh I would indeed first find out who can help me and uh also consider the the certifications that someone has. Uh I would very much like to contribute to the whole process. Also uh that someone looks at your needs and wishes, what are the requirements of a shoe. Not only in terms of appearance but also in terms of comfort. I would find that very pleasant.

Location, type/number of pairs, and durability. The location (e.g., indoors/outdoors, special occasions, work), type/number of pairs, and durability were not ranked during the focus group discussion; however, these factors were coded during the data analysis. The factors type/number of pairs and durability were not discussed extensively in this group. One subject (D1.2) wished to have water resistant TF. Another wanted TF that can be used during the summer period and is also suitable for use indoors (D1.5). With regard to location, subjects used inlays/sturdy footwear when going for a walk, travelling to work, or staying at home. For indoors, some subjects put their inlays in their slippers. Others mentioned they had to use sturdy footwear. Some bought a pair for indoor use only. Two subjects (D1.2 & D1.5) pleaded for the development of indoor TF.

D1.8: No because I have special shoes for both indoors and outdoors and I use them uh all day long. When I’m outside, I really use my outdoor shoes, which I can walk on just fine. But when I am indoors, I also use shoes because slippers and bare feet just do not work at all.

Group-TF&noHoU factors belonging to the subthemes: Use, effectiveness, usability, appearance, and prescription process of TF

Comfort and fit. The outcomes related to comfort and fit were similar to the group-noTF&noHoU. In the group-TF&noHoU, one subject (D2.5) mentioned that TF improves posture (resulting in less back pain) and makes it possible to walk long distances pain free. Some subjects (D2.6 & D2.8) emphasized the importance of feeling the surface underneath their feet, which is why they wanted footwear with thin midsoles. However, not every pebble should be felt, which is why (D2.8) mentioned this issue could be resolved by TF with inside cushioning.

D2.8:..Yes. I uh when I was still wearing non-therapeutic shoes then uh I could hardly walk due to the pain because I felt every pebble on the way. And then the pedorthists said, he/she said: ’We can take care of that by elevating the shoe from the inside and place an inlay in the shoe’.

Reducing pain. Pain reduction was ranked as the second most important factor. Again, similar to the group-noTF&noHoU, subjects stated they feel less pain when using TF. Some subjects felt pain reduction was caused by the added ankle stability. Other reasons for pain reduction were having fewer corns and a better posture. One subject (D2.8) was able to walk longer distances due to pain reduction.

D2.8: I can walk further with uh my OS on of course, but as I just said. I have 2 new knees and a new hip so that does limit me in my walking; however, that is with no pain in my feet, for sure.

Stability, weather, and material. The factor stability, specifically related to the weather and material of TF, was ranked in third place. Subjects experienced more ankle stability due to the use of TF. However, one subject (D2.3) mentioned that this is only the case for walking on flat surfaces, which is why a solution is needed for walking on unequal surfaces. In this group, TF was used more outdoors than indoors since the stability TF provides is necessary for outdoor use. Indoors, subjects kept their balance by walking barefoot or by using slippers that offer enough stability. The outcome for weather and material was similar to group-noTF&noHoU.

D2.3: Yes. uhm uh on uneven surfaces I walk off balance. Uhm I notice that I often have to adjust, also often sprain my ankle …uhm so just on the street so to say then I really walk in balance. That is very nice, but on uh on really uneven surfaces it does not work well.

Weight. The factor weight was ranked just outside the top 3 of most important factors. The group found it important to have lightweight TF for easy walking, particularly in case of weak muscles according to one subject (D2.6). One subject (D2.3) did not use TF indoors or during ball sports because of its heavy weight. This would be different if the heavy footwear could be replaced with lightweight footwear.

D2.6: Uh I used uh semi-OS years ago. Those became too heavy to use at one point, so I stopped using them. We tried uh real OS and those were fully custom made. But when I put them on, I stood and I kept standing and I absolutely could not walk on them, so uh they are in the attic and 2 years ago we tried to have OS custom made again and were unsuccessful.

Walking quality, appearance, and sole thickness. Although these factors did not make the top 3, subjects did give some input. Similar to the group-noTF&noHoU, sole thickness was discussed in relation to appearance of TF. Outcomes for walking quality were similar to group-noTF&noHoU. Some subjects (D2.5 & D2.8) mentioned better posture and pain reduction, which improves walking quality. Consequently, they were able to walk longer distances with their TF. Outcomes for appearance were also similar to the group-noTF&noHoU.

D2.5: Well if I uh my my uh my boots are on so to say, not my (therapeutic) shoes, then I uh walk for about 15 minutes and after that uh then I start to lose my balance. Then it becomes uh and if I do use my (therapeutic) shoes, then uh I walk for half an hour to an hour without uh losing my balance.

Donning and doffing, prescription process, and preventing ulceration. These 3 factors were ranked as the least important factors to influence the decision to use TF. They were also not discussed extensively. Subjects mentioned that although they find these factors important, they are not as important as other, previously mentioned factors. Subjects mentioned the donning and doffing process should be easy to perform. Some subjects (D2.7 & D2.8) suggested TF with a zipper or velcro instead of laces. One subject (D2.5) mentioned that laces are acceptable as well and that you have to get used to laces. In general, subjects were positive about the time and effort the donning and doffing of TF takes. Regarding the prescription process, some subjects (similar to group-noTF&noHoU) mentioned the importance of being involved in the process and feeling seen and heard by the physicians and/or pedorthists. They also stressed the importance of well-fitting TF. One subject (D2.6) did not use TF because it was ill-fitting. The outcome of preventing ulceration was similar to group-noTF&noHoU.

D2.7: Yes I I have uh uh for years, so first I had uh as far as that German manufacturer goes it was ’Finn Comfort’ uh and uhm I always get uh from them and also this time just Velcro and it can be also pulled up tight, just as tight as you actually want. So uh yes I like that very much. My stomach is still a little bit in the way, so tying (shoelaces) is a uh a disaster. *laughs*

D2.5: Yes what what I actually think is very important is that they fit well but also that they are seamless.… So that they are finished seamlessly and the pressure is equally distributed. That has turned out to be uh, very important.

Location, type/number of pairs, and durability. As mentioned before, location, type/ number of pairs, and durability were coded during the data analysis. During the discussion, subjects mentioned they use their TF outdoors (e.g., for work, car rides). However, some (D2.5 & D2.8) did not use their TF in the forest or at the beach. They want to keep their footwear clean and intact because they are only prescribed a limited number of pairs within a certain time frame. This makes them very cautious, and a number of subjects expressed dissatisfaction with the prescription limitation. They also noticed a lack of TF suited to different weather situations (therapeutic sandals do not yet exist). In addition, some subjects also did not use their TF indoors because they find slippers more comfortable (especially after using TF outdoors for the majority of the day).

D2.8:…Only indoors, in the house, yes then I wear slippers and of course that is not that is not so good. Since you do not have as much support but uh well so far it is going well. And in the summer I like to use uh the Birkenstock slippers. They have a reasonably decent foot bed, but of course I have no support uh for my ankle. But if I develop issues, I put them (TF) back on, similar to what the other subject also just said about walking outdoors. We like to go to Texel on vacation and walk on the beach there, and during these moments I feel it is a pity to use the (OS) shoes. So I either use my slippers when the weather is good or or I put on old shoes and think: well, this will have to do for now. Because it is a pity that the (OS) shoes get so ugly, especially from the seawater.

Group-TF&HoU factors belonging to the subthemes: Use, effectiveness, usability, appearance and prescription process of TF

Comfort and fit. Outcomes related to comfort and fit were similar to group-noTF&noHoU. The subjects in this group (group-TF&HoU) also stressed the importance of comfortable footwear in relation to improving balance and experiencing no/less pain sensations.

D3.7: But I do notice that walking comfort is a lot a lot better compared with with regular shoes. Less chance of tripping and stumbling.

Stability. The factor stability was ranked in second place. A number of subjects mentioned they often fell prior to using TF and that this changed after they started using TF. TF provides ankle stability (also mentioned in the 2 other groups), which is why users walk with more confidence, have fewer problems walking on different surfaces, have fewer back problems, and are able to use the stairs without fear of falling. Some subjects mentioned they use TF indoors as well for these reasons.

D3.6: I uh I think I told you that that I did uh fall a few times. But not any longer because of those shoes I have been wearing since March for almost 16 hours a day and that uh works perfectly.

Preventing ulceration. Preventing ulceration was ranked in third place. During the discussion, subjects mentioned the reason for prescribing TF is to prevent ulcers. All subjects mentioned they have not developed any new wounds since using well-fitting TF.

D3.1: Uh first I had low OS uh that fit well, also due to pressure spots and such, but about 5 years ago I began to have strange falls due to loss of sensation in my feet and whenever I stepped over a twig or a pebble I would strain my ankle. Subsequently, I received high ankle supportive uh OS. Afterwards it did not happen again.

Reducing pain. This factor was ranked just outside the top 3. The outcomes for this factor were similar to the other groups regarding reduced pain sensation (group-noTF&noHoU & group-TF&noHoU) and walking long distances (group-TF&noHoU).

D3.7: In my case, I do notice that I am a bit more pain free and therefore walk a bit more comfortably. Uh because besides those pressure spots, I also have rigid uh rigid toes that do not move if I load them with the wrong uh shoe. Then yes it becomes painful and because it is less painful with TF, I walk a bit easier and a bit more.

Walking quality. Although walking quality was ranked outside the top 3 and was also not discussed extensively, it was still ranked relatively high by subjects in this group. Similar to group-TF&noHoU, one subject (D3.5) could walk longer distances when using TF. This subject also mentioned that walking quality improved due to better posture, which in turn reduced back problems.

D3.5: this shoes uh the winter shoes I currently have are also higher and a bit chunky but they work really well and uh I can walk rounds of 5–7 kilometers or sometimes 10 kilometers with the dog. So I think they are fine and comfortable and I just uh I just can carry on. And well, I walk straighter so it is also better for my back.

Weather, material, location, type/number of pairs, and durability. Despite the low ranking of the factors weather and material, the subjects did have some discussion points related to these factors. The 3 other factors, location, type/number of pairs, and durability, were often coded during the data analysis and were linked to weather and material during the discussion in this particular group. In general, subjects wished for water resistant TF that they could use during rainy weather or when going to the beach or swimming pool. They also wanted to have footwear made of thinner materials for the summer. Although all-weather TF meets these criteria, subjects (similar to group-TF&noHoU) mentioned the prescription limitation. All-weather footwear has a sporty look and is not appropriate for every occasion; therefore, subjects often opt for other types of TF. As a result, they do not use their TF as often as they would like to. To protect the TF, one subject (D3.7) does not use TF while dog walking. However, some subjects cared less about protecting their footwear and continue to use it during walks. The same difference in opinion was found between subjects about wearing TF to work or during special occasions. Some use TF during working hours, whereas others said that it depends on their function and whether formal footwear is required. Some subjects do not mind wearing TF during special occasions; however, one subject (D3.5) in particular mentioned having difficulties with wearing TF during visits. Regarding indoor use, most subjects do not use their TF indoors. They often use slippers with inlays and mentioned they wanted (similar to group-noTF&noHoU) TF specifically made for indoor use. Only one subject (D3.1) uses TF indoors due to several fall accidents. Another subject (D3.5) uses slippers instead of TF when going to the swimming pool. However, this subject also had some fall accidents related to not using TF.

D3.7: The disadvantage is just, but that is my own choice, that I uh I have formal shoes for in the summer and now more sturdy shoes. But like someone else, who I just heard, I walk the dog a lot, and then I still use regular shoes uh that are weatherproof… It would have been better if I had chosen all weather shoes or something close to that for now. So yeah that is going to be a matter of waiting to to fix that. Or that the weather will be nice and I can wear the normal shoes. So something to think about is that how you can use the shoes is highly dependent on what what type of shoes you choose.

Donning and doffing. The factor donning and doffing was also ranked low. Again, some discussion points were mentioned. Subjects observed that donning of TF takes time. However, they received tips and tricks from pedorthists to speed up this process and some of these were perceived as useful. One subject (D3.5) mentioned that during visits or when going for a swim, the donning and doffing remains a hassle. For this reason, subject D3.5 always uses slippers to the swimming pool, which have resulted in a few fall accidents.

D3.5: so it is uh but indeed uhm just what you are saying about sports or swimming. In the summer, I swim in the outdoor pool a lot, and well, you use your slippers then because uh taking the socks and shoes off is a bit burdensome. So you also have a greater chance of falling. That also happened this year because I walked on slippers or other uh older shoes.

Prescription process. Prescription process received a low ranking but was discussed extensively. Experiences with the prescription process of TF differed for each subject. Some were positive and said the fitting of their TF was spot on the first time; others were negative and mentioned a process of trial and error with an unsatisfying result. Some subjects observed a lack of consensus between the different pedorthists, and they wished they could have a second opinion. The result of the fitting process greatly depends on the experience and expertise of the pedorthists. One subject (D3.8) mentioned that during the fitting 2 pedorthists were involved, and that the result was satisfactory. Subjects in this group (similar to the other groups) also mentioned they want to be included in the prescription process of TF, and they wish for physicians and/or pedorthists to listen their problems in order to find a joint solution.

D3.8:… you should also give some clear examples, sketch situations (for instance) in which you need the shoe..and I must say that they cater to that well. I now have uh 2 advisors uh who [work] together, and I must say that I do like it.

Appearance and sole thickness. Appearance received a low ranking. A number of discussion points related to this factor were mentioned. Similar to the other groups, sole thickness was linked to appearance of TF. Subjects stated they find appearance important. In general, they reported being content with the appearance of their TF, but they also stressed that this is not the main reason for using TF. However, when they were shown the researchers’ prototype shoes, which have a sporty look with thick midsoles (see S1 Fig for prototype shoes), approximately half of the group was not willing to use the shoe. They pointed out that the shoe with the thick midsoles look too chunky. In addition, one subject (D3.5) mentioned being afraid of toppling over because of the thick midsoles. The donning and doffing of the shoes with the thick midsoles was also perceived as inconvenient. Only 2 (D3.1 & D3.7) subjects were willing to use the prototype shoes if these could solve their foot problems, and one other subject (D3.3) was willing to use the shoes if they were comfortable.

D3.4: Uh well, I I would not use them, I mean, uh it might might have something to do with vanity, but I would just go for shoes with a normal thin soles that looks the most like non-therapeutic shoes. Uh these shoes, as the previous speaker indeed already mentioned, are from the past, shoes with a thick platform sole, you really would not see me walking on those.

Weight. Weight of TF received the lowest ranking and was not discussed extensively. Subjects did have some discussion points. They reported their TF is not or only slightly heavier than non-TF, but the difference is not significant. According to some subjects, you get used to the weight of TF when using it more often and heavier TF provides more stability.

D3.3: So I uh do not feel the shoes are heavier now. The ones I that I actually got 10 years ago those were really heavy shoes but over the years they have gotten much lighter.

Discussion

This study aimed to provide insight into the factors perceived as important for the use of TF by different groups of persons with DM and LOPS. The 3 focus group discussions provided mixed results. First, the factor comfort and fit was ranked as the most important factor to influence the decision to use TF in all groups. The other factors were all ranked differently by the 3 groups. The factor ulcer prevention, which is the main reason for TF prescription, was ranked in the top 3 by just one group. This was the group with a history of ulceration (group-TF&HoU). The results are further outlined in detail in the sections below. As mentioned before, it is important to note that group-noTF&noHoU is the only group that had no experience with TF (except for inlays) and that all their opinions are based on the future use of TF.

As mentioned above, the factor comfort and fit was given the highest ranking in each group. This finding is in line with the research of Arts et al., in which 33.3% of the persons with DM (n = 145) reported comfort to have the highest priority of all aspects of footwear usability [11]. It is noteworthy that the subjects in this study chose comfort and fit as the most important factor because they are not able to feel the footwear properly due to LOPS. According to Arts et al., this might be explained by the fact that subjects related comfort more to walking comfort/walking quality instead of fit of the footwear [11]. However, this reasoning is not entirely in line with the results of this study. In this study, a distinction was made between the factors walking comfort/walking quality and (comfort and) fit. Subjects were asked to rank the factors comfort and fit and walking quality separately. However, it could be that persons interpret comfort and fit as having a broader definition than only the fit of the TF, which again is in line with the study of Arts et al. and van Netten et al. that comfort (and fit) can be interpreted as more than one definition [11, 20].

The factor ulcer prevention got a low ranking by group-noTF&noHoU (second-to-last rank) and group-TF&noHoU (lowest rank). Group-TF&HoU ranked this factor third. The positive association between severity of the foot condition (Group-TF&HoU persons had poor foot health) and the importance of using TF is in line with previous literature [2426]. The reason why this factor was not ranked in first place could be related to subjects’ underestimation of their actual foot health. The study of Macfarlane and Jensen confirms this. They found that most persons with DM believed their foot health was better compared with other persons with DM, despite the fact that 62% had a history of foot complications [27]. Although a HoU resulted in a higher ranking of ulcer prevention, it was still not the most important factor. Consequently, foot complications alone do not motivate persons enough to increase their use of TF and thereby prevent ulceration. A recent study of Keukenkamp et al. analyzed the role of motivational interviewing to improve adherence to TF use [28]. Their study showed a positive association between introducing motivational interviewing during the initial prescription process and adherence to TF use. Although the effect of 1 session lasted for a short period of time only, introducing regular sessions of motivational interviewing could help to make sure persons do not underestimate the severity of their foot condition, understand the main reason for using TF, and stay motivated to use their TF.

The factor stability was another factor ranked in the top 3 by all groups. Group-noTF&noHoU and group-TF&HoU ranked this factor as the second most important factor and group-TF&noHoU ranked this factor in third place. Persons with DM and LOPS can experience postural instability due to lack of somatosensory feedback, which makes it important to use footwear that does not deteriorate their balance even more [2931]. Subjects in group-TF&noHoU and group-TF&HoU mentioned they experienced fewer stability issues when using TF compared with non-TF. Subjects in group-TF&HoU with some fall accidents prior to using TF no longer fell after they began using TF. Experiencing the benefits of having reduced stability issues and no fall accidents, seems to be a motivating factor for using TF. Most subjects in group-noTF&noHoU did not experience any falls; however, a possible fear of falling due to current (or future) stability issues with non-TF can also be a motivating factor for using TF.

The factor pain reduction was ranked in the top 3 by group-TF&noHoU. Group-TF&HoU ranked this factor just outside the top 3, and group-noTF&noHoU gave this factor the lowest ranking (least important factor). The difference in ranking between group-noTF&noHoU and the other 2 groups could be related to the impact of pain experience. During the focus group discussions, subjects from group-TF&noHoU and group-TF&HoU mentioned that using TF could reduce pain. Group-noTF&noHoU did not seem to have issues related to pain, and it is therefore not surprising they attached lower significance to this factor compared with the other 2 groups.

Group-noTF&noHoU and group-TF&noHoU ranked the factors weather and material in their top 3 of most important factors. Group-TF&HoU ranked these factors lower compared to the 2 other groups. This lower rank might be related to poorer foot.health. Other factors, closely related to weather and material, such as durability, location, type/number of pairs of TF were discussed as well. Because most subjects were mainly active indoors, it is a worrisome finding that TF was not worn indoors because of a perceived lack of TF made for indoors or other reasons [10, 32, 33]. Several companies have made TF for indoor use, according to Keukenkamp et al. However, none of these companies followed a systematic approach where they integrated the professionals’ and users’ perspectives [33]. This is why Keukenkamp et al. focused on designing TF for indoor use with the same biomechanical efficacy as TF that is intended for outdoor use [33]. They also assessed the users’ expectations and needs regarding TF for indoor use in their study. Introducing this type of TF could improve adherence to TF use, particularly because subjects in this study mentioned they were willing to use TF indoors if it was made for them [30].

The factor appearance was not ranked in the top 3 of most important factors in all groups. The ranking order also differed for each group. Group-noTF&noHo gave the highest ranking. This finding is not surprising, other studies have shown the importance of appearance in using TF in persons with DM [10, 34]. It seems that with an increasing severity of foot problems, the factor appearance becomes less important. All subjects mentioned that effectiveness (e.g., ulcer prevention) of TF was more important than appearance of TF. However, appearance was ranked higher than ulcer prevention in group-noTF&noHoU and group-TF&noHoU. Group-TF&HoU was the only group that ranked the appearance of TF lower than ulcer prevention. This finding is worrisome because it indicates that the value of using TF is only acknowledged after experiencing an ulcer.

In a previous study, the factors weight and donning and doffing were said to have an important role in adherence to TF use, especially indoors [33]. Contrary to earlier studies, where the importance of having lightweight TF was stressed, group-TF&HoU did not give it much of a significance (lowest rank) [11, 27, 34]. The 2 other groups ranked the factor higher than group-TF&HoU. According to group-TF&HoU, heavier TF does not pose any difficulties because it provides more stability. Since group-TF&HoU has less hinder from heavy footwear, it is likely that they were less frequently reminded of the weight of the footwear, and therefore did not give this factor a high ranking. Apart from the weight of the TF, subjects in all 3 groups mentioned they wanted TF with an easy donning and doffing process. Group-noTF&noHoU gave the highest ranking to this factor compared with the other 2 groups. This could be explained by the fact that the other groups are more used to donning and doffing and do not attach as much significance to this factor as the group with no prior experience.

Group-noTF&noHoU and group-TF&noHoU ranked the factor prescription process lowest. In contrast, Group-TF&HoU ranked this factor higher. This higher ranking may be explained by the fact this group experienced more issues during the prescription process compared with both other groups. Subjects in all groups did mention the importance of active listening by the physicians and/or pedorthists during the prescription process. Subjects in group-noTF&noHoU and group-TF&HoU also emphasized the importance of getting help from an experienced physicians and/or pedorthists during this process.

Strengths and limitations

An important strength of this study is its qualitative design, which gave 3 small groups of subjects the opportunity to discuss different subthemes/factors. This set-up led to in an in-depth discussion that ultimately resulted in an overview of factors perceived as important for the use of TF. A qualitative design highlights the reasoning (experiences, perceptions, and wishes) behind the importance attached to factors that influence the use of TF. A quantitative design could be the next step in analyzing whether a larger population agrees with the ranking of the different factors and also whether factors are missing. Tenny et al. advocate the use of different types of designs (qualitative and quantitative) because they provide complementary information [35]. Another strength of this study is that it included a diverse group of subjects with regards to use of TF and severity of the disease. A group of 8 subjects was found to be sufficient for reaching data saturation. However, it is possible that groups of subjects with DM and LOPS from other national or cultural backgrounds would propose other factors. This study included Dutch subjects. In other countries, the health care system, insurance system, costs, accessibility of health care, and cultural background (e.g., family role, work, religion) could be different. Therefore, generalizability of the data is applicable to the Dutch population but may not be applicable to other cultures and nationalities.

This study has some limitations. The factors that were ranked in this study emerged from the discussion based on the questions related to factors/subthemes that have been reported to (likely) influence a person’s decisions to use TF [11, 1921]. To the researchers knowledge, no framework exists that was specifically built to study the factors influencing footwear use in persons with DM and LOPS. As a consequence, the researchers might have focused on a too narrow range of (relevant) factors influencing the TF use. However, during the 3 focus group discussions, subjects did get the opportunity to introduce new factors if they felt some were lacking. None of the subjects added new factors; however, thereby increasing the probability that all relevant factors were addressed in this study. Additionally, due to the COVID-19-pandemic a neurological assessment was not performed to diagnose LOPS. Although subjects were not specially diagnosed with LOPS for this study, they were neurologically assessed by a physician who diagnosed persons with LOPS prior to this study. It was not possible to verify whether the subjects who were recruited via digital platforms and social media had indeed been diagnosed with LOPS by a physician. However, there was no reason for the subjects to be dishonest about their diagnosis since they did not benefit from participating in the study. The same goes to physical measurements to asses foot deformities. Due to the COVID-19 pandemic, the focus group discussions were held online. This can have potential disadvantages. Some subjects may be uncomfortable using technology or experience technical difficulties. Researchers cannot observe full body language of subjects and potential distractions may go unnoticed. This study aimed to reduce these disadvantages to a minimum. The researchers made sure to include subjects who had no difficulties with technology as well as subjects who lacked computer experience. The latter were guided by the researchers (and by their family) on how to participate online. Subjects who experienced technical difficulties (e.g., joining the meeting, video or microphone issues) during the focus group discussion were assisted by one of the researchers by telephone in order to solve their issue. Although full body language was not observed, the researchers could still focus on the persons’ facial cues to gain some non-verbal information. Last, since subjects joined from home, they could be distracted by their environment. To prevent unwanted distractions, the researchers asked the subjects to sit in a quiet area of their house.

Future recommendations

This study is the first qualitative study to provide an overview of factors perceived as important (and of their importance weight) for TF use by different groups of persons with DM and LOPS. This overview can be used during the prescription and the development process of TF. It offers physicians, pedorthists, and other professionals a better understanding of the factors that need to be taken into consideration when prescribing TF. Future research could focus on possible other missing factors and the development of a conceptual framework for comparing possible interactions between relevant factors [36]. This study also showed that ulcer prevention did not have the highest priority in the different groups, despite the fact that the subjects were aware that this is the main reason for TF prescription. To address this discrepancy, new education methods need to be introduced. Keukenkamp et al. introduced motivational interviewing as a new method to increase adherence to TF use [28]. Their study showed the design was successful in increasing the adherence to TF use. However, this was solely the case for a short period of time. A possible solution might be to introduce regular motivational interviewing sessions instead of only once (with 2 45-minute sessions in 1 week). Other suggestions to increase the use of TF were given by Jarl et al [26]. Their suggestion was to eliminate the temptation to use non-TF and provide a reminder to use TF [26]. This can be achieved by keeping non-TF out of sight and keeping TF in plain sight in order to send out a visual cue to use the TF and reduce the effort to retrieve non-TF from somewhere else [26]. This solution could work; however, if the reason for not using TF is related to protecting it from bad weather conditions, another solution is needed. Although all-weather TF exists, apparently these shoes do not meet all criteria for use. Either some changes need to be made to all-weather shoes, or subjects should be prescribed a new pair of TF more often. The latter option is likely to increase the costs, which is a disadvantage. Nevertheless, the cost of wound care is higher than a new pair of TF. One of the findings of this study was that most subjects did not use their TF indoors because indoor TF has not yet been developed. However, as discussed before, Keukenkamp et al. have presented a design for indoor TF following a multidisciplinary systematic design approach. Introducing this type of footwear could possibly increase indoor use of TF [33].

Conclusion

Different experiences with TF as well as a HoU influence which factors are perceived as important for TF use. The factors comfort and fit and stability/balance were ranked in the top 3 of all groups. Taking these factors into account during the development and prescription process of TF may lead to increased adherence. The most interesting finding was that subjects only realized the importance of giving priority to ulcer prevention after experiencing an ulcer. Nevertheless, even with a HoU, subjects still did not rank this factor highly. This finding emphasizes that besides focusing on the factors that are perceived as important for TF use, person-centered education on the importance of using TF to prevent ulcers is also essential.

Supporting information

S1 File. COREQ Checklist.

(XLSX)

S2 File. Interview guide for the focus group session of group-noTF&noHoU.

(PDF)

S3 File. Interview guide for the focus group sessions of group-TF&noHoU & group-TF&HoU.

(PDF)

S4 File. Final framework of the focus group discussions.

(PDF)

S1 Fig. First version of the prototype shoes with varying thickness of the midsoles.

(TIF)

S1 Table. Non-diabetes related comorbidities per focus group.

(PDF)

Acknowledgments

The authors would like to thank the subjects of the 3 focus groups for their valuable contributions, Leonie Krops for all her efforts as the moderator, and Roosmarijn Geerlings for helping with logistical matters and transcription of some of the focus group discussions.

Data Availability

The authors would like to make all anonymized data of the focus group publicaly available after acceptance of this article.The data will be available on DataverseNL and will be assigned with a digital object identifier (DOI).

Funding Statement

JMH received the funding for this work by EIT Health: https://eithealth.eu/. The Grant number was 211018. This work was part of the research project titled: ‘IndiRock'nSole’. The funder had no role in the study design, data-collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.World Health Organization. Global report on diabetes. 2016. [Google Scholar]
  • 2.Mavrogenis AF, Megaloikonomos PD, Antoniadou T, Igoumenou VG, Panagopoulos GN, Dimopoulos L, et al. Current concepts for the evaluation and management of diabetic foot ulcers. EFORT Open Rev. 2018;3(9):513–25. doi: 10.1302/2058-5241.3.180010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Edmonds M, Manu C, Vas P. The current burden of diabetic foot disease. J Clin Orthop Trauma. 2021. Jun 1;17:88–93. doi: 10.1016/j.jcot.2021.01.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Banik PC, Barua L, Moniruzzaman M, Mondal R, Zaman F, Ali L. Risk of diabetic foot ulcer and its associated factors among Bangladeshi subjects: A multicentric cross-sectional study. BMJ Open. 2020;10(2):34058. doi: 10.1136/bmjopen-2019-034058 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Boulton AJM, Armstrong DG, Albert SF, Frykberg RG, Hellman R, Sue Kirkman M, et al. Comprehensive fool examination and risk assessment: A report of the task force of the foot care interest group of the American diabetes association, with endorsement by the American association of clinical endocrinologists. Diabetes Care. 2008;31(8):1679–85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Boulton AJM. The diabetic foot. Medicine. 2014;43(1):33–7. [Google Scholar]
  • 7.Bus SA, Lawrence A L, Monteiro-Soares M, Rasmussen A, Raspovic A, Sacco IC, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev. 2020;36(1). [DOI] [PubMed] [Google Scholar]
  • 8.Chantelau E, Haage P. An Audit of Cushioned Diabetic Footwear: Relation to Patient Compliance. Diabetic Medicine. 1994;11(1):114–6. doi: 10.1111/j.1464-5491.1994.tb00240.x [DOI] [PubMed] [Google Scholar]
  • 9.Bus SA, Waaijman R, Arts M, de Haart M, Busch-Westbroek T, van Baal J, et al. Effect of custom-made footwear on foot ulcer recurrence in diabetes: A multicenter randomized controlled trial. Diabetes Care. 2013;36(12):4109–16. doi: 10.2337/dc13-0996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Waaijman R, Keukenkamp R, de Haart M, Polomski WP, Nollet F, Bus SA. Adherence to wearing prescription custom-made footwear in patients with diabetes at high risk for plantar foot ulceration. Diabetes Care. 2013;36(6):1613–8. doi: 10.2337/dc12-1330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Arts MLJ, de Haart M, Bus SA, Bakker JPJ, Hacking HGA, Nollet F. Perceived usability and use of custom-made footwear in diabetic patients at high risk for foot ulceration. J Rehabil Med. 2014;46(4):357–62. doi: 10.2340/16501977-1272 [DOI] [PubMed] [Google Scholar]
  • 12.Kossioris A, Tentolouris N, Kyriazopoulou V, Loupa C v., Markou G, Marakomichelakis G. E., et al. Initial and continued adherence to wearing appropriate footwear in people with diabetic foot disease: results of a pilot study. Hellenic Journal of Nursing Science. 2017;10(4):21–8. [Google Scholar]
  • 13.Jarl G, Lundqvist LO. Adherence to wearing therapeutic shoes among people with diabetes: A systematic review and reflections. Patient Prefer Adherence. 2016;10:1521–8. doi: 10.2147/PPA.S112275 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mack N, Woodsong C, Macqueen KM, Guest G, Namey E. Qualitative Research Methods: A data collector’s fiel guide. Family Health International (FHI); 2005. [Google Scholar]
  • 15.Krueger RA, Casey MA. Focus Groups: A Practical Guide for Applied Research. 4th ed. SAGE Publications, Inc.; 2009. [Google Scholar]
  • 16.Nabuurs-Franssen MH, Huijberts MSP, Nieuwenhuijzen Kruseman AC, Willems J, Schaper NC. Health-related quality of life of diabetic foot ulcer patients and their caregivers. Diabetologia. 2005;48(9):1906–10. doi: 10.1007/s00125-005-1856-6 [DOI] [PubMed] [Google Scholar]
  • 17.Zimny S, Schatz H, Pfohl M. Determinants and estimation of healing times in diabetic foot ulcers. J Diabetes Complications. 2002;16(5):327–32. doi: 10.1016/s1056-8727(01)00217-3 [DOI] [PubMed] [Google Scholar]
  • 18.Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care. 2007;19(6):349–57. doi: 10.1093/intqhc/mzm042 [DOI] [PubMed] [Google Scholar]
  • 19.van Netten JJ, Jannink MJA, Hijmans JM, Geertzen JHB, Postema K. Use and usability of custom-made orthopedic shoes. J Rehabil Res Dev. 2010;47(1):73–82. doi: 10.1682/jrrd.2009.08.0142 [DOI] [PubMed] [Google Scholar]
  • 20.van Netten JJ, Dijkstra PU, Geertzen JHB, Postema K. What influences a patients decision to use custom-made orthopaedic shoes? BMC Musculoskelet Disord. 2012;13:92. doi: 10.1186/1471-2474-13-92 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Paton JS, Roberts A, Bruce GK, Marsden J. Patients’ Experience of therapeutic footwear whilst living at risk of neuropathic diabetic foot ulceration: an interpretative phenomenological analysis (IPA). J Foot Ankle Res. 2014;7:16. doi: 10.1186/1757-1146-7-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.van der Wilk D, Hijmans JM, Postema K, Verkerke GJ. A user-centered qualitative study on experiences with ankle-foot orthoses and suggestions for improved design. Prosthet Orthot Int. 2018;42(2):121–8. doi: 10.1177/0309364616683981 [DOI] [PubMed] [Google Scholar]
  • 23.Pope C, Ziebland S, Mays N. The ‘Framework’ Approach. In: Pope C, Mays N, editors. Qualitative Research in Health Care. 4th ed. Wiley Blackwell; 2020. p. 123–31. [Google Scholar]
  • 24.Breuer U. Diabetic patient’s compliance with bespoke footwear after healing of neuropathic foot ulcers. Diabete et Metabolisme. 1994;20(4):415–9. [PubMed] [Google Scholar]
  • 25.Coffey L, Mahon C, Gallagher P. Perceptions and experiences of diabetic foot ulceration and foot care in people with diabetes: A qualitative meta-synthesis. Int Wound J. 2019. Feb 1;16(1):183–210. doi: 10.1111/iwj.13010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Jarl G, Tranberg R, Johansson U, Alnemo J, Lundqvist LO. Predictors of adherence to wearing therapeutic footwear among people with diabetes. J Foot Ankle Res. 2020;13:45. doi: 10.1186/s13047-020-00413-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Macfarlane DJ, Jensen JL. Factors in diabetic footwear compliance. J Am Podiatr Med Assoc. 2003;93(6):485–91. doi: 10.7547/87507315-93-6-485 [DOI] [PubMed] [Google Scholar]
  • 28.Keukenkamp R, Merkx MJ, Busch-Westbroek TE, Bus SA. An Explorative Study on the Efficacy and Feasibility of the Use of Motivational Interviewing to Improve Footwear Adherence in Persons with Diabetes at High Risk for Foot Ulceration. J Am Podiatr Med Assoc. 2018;108(2):90–9. doi: 10.7547/16-171 [DOI] [PubMed] [Google Scholar]
  • 29.Crews RT, Shen BJ, Campbell L, Lamont PJ, Boulton AJM, Peyrot M, et al. Role and determinants of Adherence to off-loading in diabetic foot ulcer healing: A prospective investigation. Diabetes Care. 2016;39(8):1371–7. doi: 10.2337/dc15-2373 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Horstink KA, van der Woude LH, Hijmans JM. Effects of offloading devices on static and dynamic balance in patients with diabetic peripheral neuropathy: A systematic review. Rev Endocr Metab Disord. 2021;22(2):325–35. doi: 10.1007/s11154-020-09619-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Albright BC, Woodhull-Smith WM. Rocker bottom soles alter the postural response to backward translation during stance. Gait Posture. 2009. Jul 1;30(1):45–9. doi: 10.1016/j.gaitpost.2009.02.012 [DOI] [PubMed] [Google Scholar]
  • 32.Armstrong DG, Abu-Rumman PL, Nixon BP, Boulton AJM. Continuous Activity Monitoring in Persons at High Risk for Diabetes-Related Lower-Extremity Amputation. J Am Podiatr Med Assoc. 2001;91(9):451–5. doi: 10.7547/87507315-91-9-451 [DOI] [PubMed] [Google Scholar]
  • 33.Keukenkamp R, van Netten J, Busch-Westbroek TE, Nollet F, Bus SA. Users’ needs and expectations and the design of a new custom-made indoor footwear solution for people with diabetes at risk of foot ulceration. Disabil Rehabil. 2021;30:1–8. doi: 10.1080/09638288.2021.2003878 [DOI] [PubMed] [Google Scholar]
  • 34.Williams AE, Nester CJ. Patient perceptions of stock footwear design features. Prosthet Orthot Int. 2006;30(1):61–71. doi: 10.1080/03093640600574425 [DOI] [PubMed] [Google Scholar]
  • 35.Tenny S, Brannan JM, Brannan GD. Qualitative Study. StatPearls Publishing; 2022. [Google Scholar]
  • 36.Jarl G. Methodological considerations of investigating adherence to using offloading devices among people with diabetes. Patient Prefer Adherence. 2018;12:1767–75. doi: 10.2147/PPA.S175738 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Miquel Vall-llosera Camps

6 Sep 2022

PONE-D-22-12625Factors influencing the use of therapeutic footwear in patients with diabetes mellitus and loss of protective sensation. A focus group studyPLOS ONE

Dear Dr. Malki,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

I would like to sincerely apologise for the delay you have incurred with your submission. We have now received four completed reviews; the comments are available below. The reviewers have raised significant scientific concerns about the study that need to be addressed in a revision.

Please revise the manuscript to address all the reviewer's comments in a point-by-point response in order to ensure it is meeting the journal's publication criteria. Please note that the revised manuscript will need to undergo further review, we thus cannot at this point anticipate the outcome of the evaluation process.

Please submit your revised manuscript by Oct 20 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Miquel Vall-llosera Camps

Senior Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. We suggest you thoroughly copyedit your manuscript for language usage, spelling, and grammar. If you do not know anyone who can help you do this, you may wish to consider employing a professional scientific editing service.

Whilst you may use any professional scientific editing service of your choice, PLOS has partnered with both American Journal Experts (AJE) and Editage to provide discounted services to PLOS authors. Both organizations have experience helping authors meet PLOS guidelines and can provide language editing, translation, manuscript formatting, and figure formatting to ensure your manuscript meets our submission guidelines. To take advantage of our partnership with AJE, visit the AJE website (http://learn.aje.com/plos/) for a 15% discount off AJE services. To take advantage of our partnership with Editage, visit the Editage website (www.editage.com) and enter referral code PLOSEDIT for a 15% discount off Editage services.  If the PLOS editorial team finds any language issues in text that either AJE or Editage has edited, the service provider will re-edit the text for free.

Upon resubmission, please provide the following:

The name of the colleague or the details of the professional service that edited your manuscript

A copy of your manuscript showing your changes by either highlighting them or using track changes (uploaded as a *supporting information* file)

A clean copy of the edited manuscript (uploaded as the new *manuscript* file).

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc

unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

Additional Editor Comments:

In general, we would expect qualitative studies to include the following: 1) defined objectives or research questions; 2) description of the sampling strategy, including rationale for the recruitment method, participant inclusion/exclusion criteria and the number of participants recruited; 3) detailed reporting of the data collection procedures; 4) data analysis procedures described in sufficient detail to enable replication; 5) a discussion of potential sources of bias; and 6) a discussion of limitations. Please pay attention to these requirements when revising your manuscript.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: N/A

Reviewer #4: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: No

Reviewer #4: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

Reviewer #3: No

Reviewer #4: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Factors influencing the use of therapeutic footwear in patients with diabetes mellitus and loss of protective sensation.

The aim of the present study was to provide insight in the factors that are perceived important in the use of TF for different groups of patients with DM and DPN. To this aim the authors evaluated three different groups, a) patients without therapeutic footwear (TF) and no history of DFU, b) patients without TF and history of DFU and c) patients with TF and DFU.

The study is nicely conducted and the results are nicely presented, despite that, some changes must be made before publication:

INTRODUCTION:

- To long introduction, the authors must shorten it before publication.

STUDY DESIGN AND DATA ALLOCATION

- The authors state in lines 149-151 that it was not possible due to Covid-19 pandemic to assess physical measurements, it could be a bias in the selection of inclusion and exclusion criteria, it must be discussed as a limitation.

- LOPS: authors declare that patients with LOPS were included in the research, but auto perception of LOPS is not a valid method to diagnose DPN and LOPS, authors must explain it in depth and if no neurological assessment was performed, authors might explain how it can be done and if no possible add as a limitation in the discussion section accordingly.

-

RESULTS:

- Higher risk of ulcer occurrence patients seem to have higher knowledge about DFU complications derived from the results presented in table 2, despite this, the qualitative analyses of the results do not let us to reach any conclusion.

- Also, the three studied groups were well balanced in terms of baseline characteristics. That said, the plausibility of the results may be limited by the relatively low number of participants. Was a sample size calculation performed? 8 patients per groups is very small, this need to be included as a limitation of the study.

- The paper has a big weakness due to the lack of quantitative data, for further research, authors should confirm this results in a quantitative study.

DISCUSSION:

- The discussion is coherent, but I recommend shortening it.

Reviewer #2: Thanky you for your article which is very timely in the therapeutic footwear and diabetic foot field.

I have some initial suggestions that may help your manuscript develop further:

-Even though you have made clear that ethics approval was not required, i feel that your work does require ethical approval for an international publication. Therefore can get retrospective approval?

-you have talked about the 'tool' of qualitative research, which I feel is not the right term to use. I also feel it would be nice for you to clarify that you are 'exploring new knowledge generation' which justifies this type of methodology.

- some of your references in the introduction (4, 11,12,13) are quite old. Are there any more recent? if not state that this is a gap in the literature

line 64 - reword. patients who have previously suffered.....for a recurrence of ulceration

line 65 - can you use international guidelines? as well as national?

-after reading the introduction, i am not clear if you are trying to influence design of footwear or influence behaviour change to wear TF. Behavuior change is a different concept and area that you may want to differentiate in this section to make it clear to the reader your intentions.

line 145 - how did you measure TF use in the questionnaire?

Results:

Table 1 is slightly confusing; too many abbreviations, no legend, too many groups of data grouped

table 2 - the first part is a lot of repeated text for the three groups; could you introduce the ranking numbers as another column?

-after reading the main findings, there appears a lot of repetition to each group within the text. This made it difficult to read and to compare and contrast amongst groups. You could condense much of this with a re-working of the presentation.

-your discussion similarly has lots of repetition as you have tried to seperate the groups and report on each. As above suggestion, try to condense and bring your findings and themes together.

your recommendations are very good

Reviewer #3: COMMENT FOR THE AUTHORS

1. Line 30 rather than “do not use therapeutic footwear sufficiently, rewrite as “do not use therapeutic footwear consistently, properly, regularly or as expected.

2. Line 37, “TF & HoU)” should come first to allow for the writing in full for (HoU) history of ulceration

3. Line 37: the content of the bracket should come after the word “discussions”.

4. The presentation of the abstract has not sufficiently provided comprehensive details of the focus of the study which included giving detailed information about the factors that factors that influence or could influence the use of therapeutic footwear. The authors should list the factors based on the outcome of the said focus groups.

5. The use of personal pronoun should be avoided as much as possible in all aspect of the manuscript. Every instance of personal should be rephrased in 3rd person pronoun

Eg: lines 31-32: “If we understand what factors could influence their use” Better rephrased as “If factors that influence their use are understood.”

Instead of “There, we aimed to provide insight in the factors that……” Better rephrased as “Therefore, this study aimed to provide insight in the factors that ……”

6. Line 67: correct “hereby” to “Thereby”

7. Line 81: “Two studies in this review” should be corrected as “Two studies in the review”

8. Line 92: “Currently, we are designing prototype shoes……” should be rephrased as “Currently, the authors of this study are designing prototype shoes …..”

9. Lines 131-134: The groups described should be done properly by differentiated them using numerical number.

10. Detailed information as it relates to the number of participants recruited for the study on the basis of the recruitment channels should be presented and included in the study. That will possibly be of help to future researchers in the aspect of considering recruitment channel for related study design.

11. How many participants were involved in the online questionnaire? This information should be provided.

12. Line 153-154: on how the discussion was organised online? Or “on how the discussion was to be organised” Please rewrite the sentence for clarity.

13. Line: 155: Once all participants joined ….. Should be corrected as “When all participants joined ….”

14. Line: 157; Correct “Hereafter” as “Thereafter”

15. Table 2: The word “patients” should be replaced with “persons” or “subjects”.

16. There is the need for the authors to include more references to support the discussion. The total number of cited references is too limited for an academic paper of this magnitude. The authors should search thoroughly as there are series of published articles in this area of research.

The authors may can consider using the following keywords:

“Therapeutic footwear, Neuropathic Foot, Diabetes”

to search for very current and relevant and updated literatures.

Articles published within the last three years (2019 to date) should form significant aspect in the study to enable the authors provide updated information in the field to the readers.

Reviewer #4: Thank you so much for considering me as a reviewer of this study. This is an article of importance in its field and addressing contemporary issues. Well Done to the Authors!

Some minor comments are proposed in this regard as below.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Richard Collings

Reviewer #3: Yes: Stanley I.R. Okoduwa, PhD,

Department of Biochemistry, School of Basic Medical Sciences, Babcock University, Ilishan-Remo, Nigeria.

Reviewer #4: Yes: Sayed Ahmed

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: Reviewer notes.docx

Attachment

Submitted filename: Reviewer Comments_ Sayed Ahmed.docx

PLoS One. 2023 Jan 12;18(1):e0280264. doi: 10.1371/journal.pone.0280264.r002

Author response to Decision Letter 0


25 Oct 2022

Reviewer #1

6. Introduction

To long introduction, the authors must shorten it before publication.

We agree with the reviewer and, consequently, shortened the introduction.

The initial word count was: 1003, which is currently at: 627.

7. Study design and data allocation

The authors state in lines 149-151 that it was not possible due to Covid-19 pandemic to assess physical measurements, it could be a bias in the selection of inclusion and exclusion criteria, it must be discussed as a limitation.

Agreed, changed in manuscript

8. LOPS: authors declare that patients with LOPS were included in the research, but auto perception of LOPS is not a valid method to diagnose DPN and LOPS, authors must explain it in depth and if no neurological assessment was performed, authors might explain how it can be done and if no possible add as a limitation in the discussion section accordingly.

Agreed, changed in manuscript

9. Results

Higher risk of ulcer occurrence patients seem to have higher knowledge about DFU complications derived from the results presented in table 2, despite this, the qualitative analyses of the results do not let us to reach any conclusion.

Following the remark, we made changes to table 2 to clarify the information provided in the table.

From (the revised) table 2 one could gather that all groups have sufficient knowledge on diabetes related complications. In fact, the most important complication (DFU) was mentioned by all groups. All groups also knew that therapeutic footwear is prescribed to prevent DFUs. However, the difference between the groups (based on the results of the qualitative study) is that it seems that one has to have experienced an ulcer before evaluating the factor ‘ulcer prevention’ important enough (top 3 in table 2) to start using therapeutic footwear (TF). This means that in table 2 the emphasis for the difference between group-noTF&noHoU, group-TF&noHoU and group-TF&HoU, is on the experience of an ulcer rather than on the risk for an ulcer occurrence.

The conclusion that is reached from this qualitative study is that it seems that patients have to experience an ulcer before to find ‘ulcer prevention’ important enough to start using TF. Even with experiencing an ulcer before, patients do not rank this factor the highest. This finding emphasizes that besides focusing on the factors that are perceived as important by different groups of persons with DM, one also has to find a way to educate (motivate) persons on the importance of using TF to prevent ulcers.

10. Also, the three studied groups were well balanced in terms of baseline characteristics. That said, the plausibility of the results may be limited by the relatively low number of participants. Was a sample size calculation performed? 8 patients per groups is very small, this need to be included as a limitation of the study.

We agree with the reviewer that for a quantitative study, 8 patients per group would have been too small. However, for a qualitative analysis a group of 8 people is a good size. We based our number of patients per group on literature about qualitative studies. Below you can find studies where it is stated that it is preferred/required to have a group of around 8 for a qualitative study in the form of a focus group.

- https://www.semanticscholar.org/paper/Designing-and-Conducting-Focus-Group-Interviews-Krueger/eb7499b9e559c969d0a8e7bceafd36adc4578eaf

- https://www.fhi360.org/sites/default/files/media/documents/Qualitative%20Research%20Methods%20-%20A%20Data%20Collector's%20Field%20Guide.pdf

- https://pubmed.ncbi.nlm.nih.gov/29262162/

11. The paper has a big weakness due to the lack of quantitative data, for further research, authors should confirm this results in a quantitative study.

We thank the reviewer to bring this point to our attention. We specifically chose a qualitative analysis of the focus group data since we were interested in understanding what factors patients find important (and their importance weight) in using therapeutic footwear and the reasoning (experience, attitude, wishes) behind the importance of the factors for the patients. Qualitative data (gathered from focus groups) on behavior, experience, and attitude can be difficult to quantify, with the possibility of losing the context and narrative behind the qualitative data. According to Tenny et al. one should not quantify data if they are not meant to be quantified. But indeed, we do think that next to a qualitative study (methods such as interviews and focus groups etc.), a quantitative study (based on a quantitative method such surveys and questionnaires etc.) will have an added value. Through a survey one could analyze whether a larger patient population agrees with the ranking of the different factors and if not, to rearrange the rank. One could also ask whether there are some missing factors etc. The study of Tenny et al. (see for the link below) emphasis the importance of both quantitative and qualitative studies and how they can be complementary to each other. https://pubmed.ncbi.nlm.nih.gov/29262162/

12. Discussion

The discussion is coherent, but I recommend shortening it.

We agree with the reviewer and shortened the discussion accordingly.

The initial word count was: 3194, which is currently at: 2470.

Reviewer #2

13. Introduction

Even though you have made clear that ethics approval was not required, i feel that your work does require ethical approval for an international publication. Therefore can get retrospective approval?

Thank you for this suggestion. It may be unclear that with a non-WMO approval we still had to follow the required legal acts and/or guidelines: the Medical Treatment Agreement (WGBO), General Data Protection Regulation (GDPR) and codes of conduct of the FEDERA (Federation of Medical Scientific Institutions). This is why we added the following line to the manuscript: ‘The required legal acts and/or guidelines, the Medical Treatment Agreement (WGBO), General Data Protection Regulation (GDPR) and codes of conduct of the FEDERA (Federation of Medical Scientific Institutions), were followed.’

We do not think a retrospective approval is needed for the following reasons:

The Medical Ethics Committee (METc) of the University Medical Center Groningen is legally authorized to evaluate research that is conducted by the UMCG. The METc decided our study is not subject to the Medical Research Involving Human Subjects Act (WMO). Research is subject to the WMO if the following criteria are met:

1. It concerns medical scientific research and

2. Participants are subject to procedures or are required to follow rules of behaviour.

Our participants were not subject to procedures or were required to follow rules of behaviour. This is why we agree with the decision of the METc that our study does not need a WMO approval. This does not mean that we did not follow other legal acts and/or guidelines. We followed the required legal acts and/or guidelines: the Medical Treatment Agreement (WGBO), General Data Protection Regulation (GDPR) and codes of conduct of the FEDERA (Federation of Medical Scientific Institutions). There has been also several international publications that did not require a WMO approval. Even studies published by PLOS ONE:

- User-relevant factors determining prosthesis choice in persons with major unilateral upper limb defects: A meta-synthesis of qualitative literature and focus group results (europepmc.org)

- Pre-operative rehabilitation for dysvascular lower-limb amputee patients: A focus group study involving medical professionals | PLOS ONE

14. you have talked about the 'tool' of qualitative research, which I feel is not the right term to use. I also feel it would be nice for you to clarify that you are 'exploring new knowledge generation' which justifies this type of methodology.

Agreed, changed in manuscript

15. some of your references in the introduction (4, 11,12,13) are quite old. Are there any more recent? if not state that this is a gap in the literature

We agree with the reviewer and replaced the references.

16. line 64 - reword. patients who have previously suffered.....for a recurrence of ulceration

We agree with the reviewer, however we removed line 64 to shorten the introduction.

17. line 65 - can you use international guidelines? as well as national?

Thank you for your suggestion. Line 65 was not phrased clearly, the national guidelines follow the ‘International working Group on the Diabetic Foot’ (IWGDF) guidelines. Line 65 is changed in the manuscript and we added the reference of the IWGDF guideline: Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update) (iwgdfguidelines.org)

18. After reading the introduction, i am not clear if you are trying to influence design of footwear or influence behaviour change to wear TF. Behavuior change is a different concept and area that you may want to differentiate in this section to make it clear to the reader your intentions.

We agree and changed the introduction where we now describe more clearly that the goal of our study is to get an overview of factors that are perceived as important for the design of footwear and their importance weight in the use of therapeutic footwear in different patient groups. The end goal (which is outside the scope of this study) is that the results of our study will help in the design of footwear and the selection process of them which in turn may lead to an increase in the use of therapeutic footwear and prevent further deterioration of the patient’s foot condition (e.g. diabetic foot ulcers).

19. line 145 - how did you measure TF use in the questionnaire?

We agree with the reviewer that we should be more explicit. We therefor added a line that the information on the disease and TF use were gathered from the questionnaire through a self-report.

20. Results:

Table 1 is slightly confusing; too many abbreviations, no legend, too many groups of data grouped

Agreed, we changed manuscript accordingly

21. table 2 - the first part is a lot of repeated text for the three groups; could you introduce the ranking numbers as another column?

Agreed, changed in manuscript

22. after reading the main findings, there appears a lot of repetition to each group within the text. This made it difficult to read and to compare and contrast amongst groups. You could condense much of this with a re-working of the presentation.

We agree with the reviewer and shortened the result section by avoiding the repetition the reviewer refers to.

The initial word count was: 5593 (with the patient quotes), which is currently at: 4613 (including the patient quotes).

23. your discussion similarly has lots of repetition as you have tried to seperate the groups and report on each. As above suggestion, try to condense and bring your findings and themes together

We agree with the reviewer and shortened the discussion by avoiding the repetition the reviewer refers to.

The initial word count was: 3194, which is currently at: 2470.

Reviewer #3

24. Line 30 rather than “do not use therapeutic footwear sufficiently, rewrite as “do not use therapeutic footwear consistently, properly, regularly or as expected.

Agreed, changed in manuscript

25. Line 37, “TF & HoU)” should come first to allow for the writing in full for (HoU) history of ulceration

Agreed, changed in manuscript

26. Line 37: the content of the bracket should come after the word “discussions”.

Agreed, changed in manuscript

27. The presentation of the abstract has not sufficiently provided comprehensive details of the focus of the study which included giving detailed information about the factors that factors that influence or could influence the use of therapeutic footwear. The authors should list the factors based on the outcome of the said focus groups.

We agree and changed the abstract where we listed the top 3 ranked factors of each group. We focused on the top 3 ranked factors due to the limited amount of words instructed by the journal.

28. The use of personal pronoun should be avoided as much as possible in all aspect of the manuscript. Every instance of personal should be rephrased in 3rd person pronoun

Eg: lines 31-32: “If we understand what factors could influence their use” Better rephrased as “If factors that influence their use are understood.”

Instead of “There, we aimed to provide insight in the factors that……” Better rephrased as “Therefore, this study aimed to provide insight in the factors that ……”

Agreed, changed in manuscript

The initial sentences of the manuscript (including the background section of the abstract) are changed by Sonja Hintzen, who thoroughly edited our manuscript for language usage, which is why not the exact sentences, that were given as example by the reviewer (lines 31-32), are seen in the background section of the abstract. However, throughout the whole manuscript we rephrased sentences with personal pronoun to 3rd pronoun.

29. Line 67: correct “hereby” to “Thereby”

Agreed, changed in manuscript, however the initial sentence was taken out and rephrased by Sonja Hintzen, who edited our manuscript for language usage.

30. Line 81: “Two studies in this review” should be corrected as “Two studies in the review”

Agreed, changed in manuscript. The initial sentence was taken out and rephrased by Sonja Hintzen, who edited our manuscript for language usage.

However we followed the reviewers comment to change ‘this’ review into ‘the’ review.

31. Line 92: “Currently, we are designing prototype shoes……” should be rephrased as “Currently, the authors of this study are designing prototype shoes …..”

Thank you for the suggestion, however we removed line 92 to shorten the introduction.

32. Lines 131-134: The groups described should be done properly by differentiated them using numerical number.

In the manuscript the three groups were differentiated and shown in Figure 1. The reference to Figure 1 was not done properly (Line 117 gave an error). We made sure the reference to the Figure is corrected.

33. Detailed information as it relates to the number of participants recruited for the study on the basis of the recruitment channels should be presented and included in the study. That will possibly be of help to future researchers in the aspect of considering recruitment channel for related study design.

The researchers of this study were not the main physicians treating the patients. Due to privacy reasons the researcher do not know exactly the number of patients recruited from each channel.

34. How many participants were involved in the online questionnaire? This information should be provided.

We agree and added this information in the manuscript.

35. Line 153-154: on how the discussion was organised online? Or “on how the discussion was to be organised” Please rewrite the sentence for clarity.

Agreed, changed in manuscript

36. Line: 155: Once all participants joined ….. Should be corrected as “When all participants joined ….

Agreed, changed in manuscript. The initial sentence was taken out and rephrased by Sonja Hintzen, who edited our manuscript for language usage.

However we followed the reviewers comment to change ‘Once..’ into ‘When..’.

37. Line: 157; Correct “Hereafter” as “Thereafter”

Agreed, changed in manuscript

38. Table 2: The word “patients” should be replaced with “persons” or “subjects”.

Agreed, changed in manuscript.

In Table 2 we changed the word ‘patients’ to ‘subjects’ since ‘subjects’ is a term that is also used in the PLOS ONE journal guidelines.

39. There is the need for the authors to include more references to support the discussion. The total number of cited references is too limited for an academic paper of this magnitude. The authors should search thoroughly as there are series of published articles in this area of research.

The authors may can consider using the following keywords:

“Therapeutic footwear, Neuropathic Foot, Diabetes”

to search for very current and relevant and updated literatures.

Articles published within the last three years (2019 to date) should form significant aspect in the study to enable the authors provide updated information in the field to the readers.

The reviewer rightfully mentions the number of papers is too limited for the discussion sections. We therefor added a number of relevant references to the discussion section.

Not all the added references are from 2019-2022, however many studies related to the use of therapeutic footwear (and the factors that are related to therapeutic footwear) are older. Even a review from 2019 (see below for the link of the study) where the objective was, to identify in the literature aspects related to the recommendation of health professionals and the use of therapeutic footwear by patients with Diabetes Mellitus, the studies found and were interesting to our study were not very recent.

chrome-extension://dagcmkpagjlhakfdhnbomgmjdpkdklff/enhanced-reader.html?openApp&pdf=https%3A%2F%2Flink.springer.com%2Fcontent%2Fpdf%2F10.1007%2Fs40200-019-00428-9.pdf

Reviewer #4

40. Page 3, Line 56, Please check the space between the reference and the following lines. Also, the spacing is inconsistent in other areas, such as Page 3, line 63 and other references on this page and also throughout the article. Please make them all consistent.

Agreed, changed in manuscript

41. Page 4, Line 101. Please check grammar for “proofed”.

We agree, however we removed Line 101 in order to shorten the introduction.

42. Page 5, Line 123. Please clarify if the Orthopedic shoe technicians are titled as “Pedorthists” in the Netherlands. If so, please use the appropriate professional title and please check other studies from the Netherlands have been using the term.

Ref: https://onlinelibrary.wiley.com/doi/full/10.1002/dmrr.3237

Agreed, changed in manuscript

43. Page 6, Line 150, Please clarify if there was an option to collect or verify the patient data such as LOPS, and foot deformities from a verified medical record source or referral source other than the patient’s self-report on them.

We added a number of lines to clarify how the information on the LOPS was gathered.

44. Page 11, Line 242. Please be consistent with using Capital for “ Appearance” and “prescription process”.

Agreed, changed in manuscript

Attachment

Submitted filename: Response to reviewers.docx

Decision Letter 1

Dimitrios Sokratis Komaris

12 Dec 2022

PONE-D-22-12625R1Factors influencing the use of therapeutic footwear in persons with diabetes mellitus and loss of protective sensation: a focus group studyPLOS ONE

Dear Dr. Malki,

Thank you for submitting your manuscript to PLOS ONE.

All four reviewers that have previously reviewed your manuscript agree that the current version is significantly improved, and all previous comments have been satisfactory addressed. The manuscript is technically sound, and it is suitable for publication.

I have additionally asked a fifth reviewer to evaluate your manuscript, and they agree that the comments raised in the previous round of review have been all addressed, and the manuscript is now acceptable for publication. However, a minor comment was raised regarding the referenced exclusion criteria of the study (please see comments bellow). Kindly address the reviewer’s concerns and submit your manuscript for publication.

Thank you very much for responding to each comment; I look forward to receiving your final version.

Please submit your revised manuscript by Jan 26 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Dimitrios Sokratis Komaris, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

Reviewer #3: All comments have been addressed

Reviewer #4: All comments have been addressed

Reviewer #5: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Partly

Reviewer #5: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

Reviewer #4: Yes

Reviewer #5: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear authors,

Thank you very much for the responses, all the queries have been addressed consequently.

The quality of the paper improved.

I encourage the authors to continue researching in this field.

Congrats on it.

Reviewer #2: (No Response)

Reviewer #3: (No Response)

Reviewer #4: Well done with the corrections. It is a good article and good area to conduct research on. Keep up the research work to contribute to the scientific community.

Reviewer #5: Reviewers' comments:

Adherence to treatment has been considered as an important factor to influence those clinical outcomes of RCTs. Patients who were adherent had significantly better outcomes than those who were nonadherent. This research plays an important role in discovering new information. The authors have further improved the manuscript according to reviewers’ comments and also explained every question reasonably. However, the following question require further clarification:

1.The exclusion criteria are too simple. Many comorbidities such as cardiac insufficiency, severe hepatic and renal dysfunction, malignant tumor, unsteady gait, lower extremity edema, et.al may influence the choice of the main reason regarding low adherence to use of TF. The characteristics of the subjects should show more information of comorbidities and complications.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr. Mateo López Moral

Reviewer #2: Yes: Richard Collings

Reviewer #3: Yes: Stanley I.R. Okoduwa, PhD, [Directorate of Research and Development, Nigerian Institute of Leather and Science Technology, Zaria - Nigeria]

Reviewer #4: Yes: Sayed Ahmed

Reviewer #5: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Jan 12;18(1):e0280264. doi: 10.1371/journal.pone.0280264.r004

Author response to Decision Letter 1


22 Dec 2022

Reviewer 5 comment:

Adherence to treatment has been considered as an important factor to influence those clinical outcomes of RCTs. Patients who were adherent had significantly better outcomes than those who were nonadherent. This research plays an important role in discovering new information. The authors have further improved the manuscript according to reviewers’ comments and also explained every question reasonably. However, the following question require further clarification:

1.The exclusion criteria are too simple. Many comorbidities such as cardiac insufficiency, severe hepatic and renal dysfunction, malignant tumor, unsteady gait, lower extremity edema, et.al may influence the choice of the main reason regarding low adherence to use of TF. The characteristics of the subjects should show more information of comorbidities and complications.

Authors’ response:

We would like to thank the reviewer to bring this point to our attention. In order to provide more information on the comorbidities and complications, we made changes to Table 1. The most frequent comorbidities in the three focus groups were shown in Table 1. The less frequent comorbidities (extended comorbidities list), are summarized as ‘other’ in Table 1. However, for the interested readers, we also provided another table (S1 Table; table in the ‘supporting information’), with each of the less frequent comorbidity listed per focus group and not summarized as ‘other’.

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 2

Dimitrios Sokratis Komaris

26 Dec 2022

Factors influencing the use of therapeutic footwear in persons with diabetes mellitus and loss of protective sensation: a focus group study

PONE-D-22-12625R2

Dear Dr. Malki,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Dimitrios Sokratis Komaris, Ph.D

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Dimitrios Sokratis Komaris

3 Jan 2023

PONE-D-22-12625R2

Factors influencing the use of therapeutic footwear in persons with diabetes mellitus and loss of protective sensation: a focus group study

Dear Dr. Malki:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Dimitrios Sokratis Komaris

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. COREQ Checklist.

    (XLSX)

    S2 File. Interview guide for the focus group session of group-noTF&noHoU.

    (PDF)

    S3 File. Interview guide for the focus group sessions of group-TF&noHoU & group-TF&HoU.

    (PDF)

    S4 File. Final framework of the focus group discussions.

    (PDF)

    S1 Fig. First version of the prototype shoes with varying thickness of the midsoles.

    (TIF)

    S1 Table. Non-diabetes related comorbidities per focus group.

    (PDF)

    Attachment

    Submitted filename: Reviewer notes.docx

    Attachment

    Submitted filename: Reviewer Comments_ Sayed Ahmed.docx

    Attachment

    Submitted filename: Response to reviewers.docx

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    The authors would like to make all anonymized data of the focus group publicaly available after acceptance of this article.The data will be available on DataverseNL and will be assigned with a digital object identifier (DOI).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES